| Christopher Griffith Jordan, DO | |
|
5450 Clearfork Main St Ste 200, Fort Worth, TX 76109-3562 | |
| (682) 707-4545 | |
| (817) 804-8160 |
| Full Name | Christopher Griffith Jordan |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 25 Years |
| Location | 5450 Clearfork Main St Ste 200, Fort Worth, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679523625 | NPI | - | NPPES |
| 1500738-01 | Medicaid | TX | |
| 1500738-02 | Medicaid | TX | |
| 150073803 | Medicaid | TX | |
| 8EF297 | Other | TX | BCBS |
| 009913293 | Medicaid | AL |
| Facility Name | Location | Facility Type |
|---|---|---|
| Montrose Memorial Hospital | Montrose, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Montrose Memorial Hospital Inc | 1658272992 | 61 |
News Archive
NexMed, Inc., a specialty CRO and a developer of products based on the NexACT technology, today announced that the NASDAQ Listing Qualifications Panel (the "Panel") has determined that NexMed has evidenced compliance with the market value of listed securities requirement for continued listing on The NASDAQ Capital Market by evidencing a market capitalization in excess of $35 million for a minimum of ten consecutive trading days, in lieu of the $2.5 million in stockholder's equity as required by the Panel's decision dated December 17, 2009.
Auxilium Pharmaceuticals, Inc., a fully integrated specialty biopharmaceutical company, announced today that the U.S. Food and Drug Administration has approved XIAFLEX (collagenase clostridium histolyticum, or CCH), an in-office, biologic for the treatment of Peyronie's disease. XIAFLEX is the first and only FDA-approved treatment proven effective for PD in men with a palpable plaque and a curvature deformity of 30 degrees or greater at the start of therapy.
The Pennsylvania Department of Public Welfare's stepped-up efforts over the summer to target waste, fraud, and abuse quickly bore fruit in the fall. Adult Medicaid enrollment alone was down 109,000 through November. … Now, DPW has suddenly changed its reporting method. Revised calculations show a decline of just 6,000 participants for the same period. And when December is added in, enrollment is up by 23,000 since August.
As probes of Veterans Affairs hospitals continue, Democratic and Republican candidates are pointing fingers and attempting to find political advantage in the controversy.
› Verified 9 days ago
| Entity Name | Montrose Memorial Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285803635 PECOS PAC ID: 1658272992 Enrollment ID: O20040119000579 |
News Archive
NexMed, Inc., a specialty CRO and a developer of products based on the NexACT technology, today announced that the NASDAQ Listing Qualifications Panel (the "Panel") has determined that NexMed has evidenced compliance with the market value of listed securities requirement for continued listing on The NASDAQ Capital Market by evidencing a market capitalization in excess of $35 million for a minimum of ten consecutive trading days, in lieu of the $2.5 million in stockholder's equity as required by the Panel's decision dated December 17, 2009.
Auxilium Pharmaceuticals, Inc., a fully integrated specialty biopharmaceutical company, announced today that the U.S. Food and Drug Administration has approved XIAFLEX (collagenase clostridium histolyticum, or CCH), an in-office, biologic for the treatment of Peyronie's disease. XIAFLEX is the first and only FDA-approved treatment proven effective for PD in men with a palpable plaque and a curvature deformity of 30 degrees or greater at the start of therapy.
The Pennsylvania Department of Public Welfare's stepped-up efforts over the summer to target waste, fraud, and abuse quickly bore fruit in the fall. Adult Medicaid enrollment alone was down 109,000 through November. … Now, DPW has suddenly changed its reporting method. Revised calculations show a decline of just 6,000 participants for the same period. And when December is added in, enrollment is up by 23,000 since August.
As probes of Veterans Affairs hospitals continue, Democratic and Republican candidates are pointing fingers and attempting to find political advantage in the controversy.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christopher Griffith Jordan, DO 5450 Clearfork Main St Ste 200, Fort Worth, TX 76109-3562 Ph: (682) 707-4545 | Christopher Griffith Jordan, DO 5450 Clearfork Main St Ste 200, Fort Worth, TX 76109-3562 Ph: (682) 707-4545 |
News Archive
NexMed, Inc., a specialty CRO and a developer of products based on the NexACT technology, today announced that the NASDAQ Listing Qualifications Panel (the "Panel") has determined that NexMed has evidenced compliance with the market value of listed securities requirement for continued listing on The NASDAQ Capital Market by evidencing a market capitalization in excess of $35 million for a minimum of ten consecutive trading days, in lieu of the $2.5 million in stockholder's equity as required by the Panel's decision dated December 17, 2009.
Auxilium Pharmaceuticals, Inc., a fully integrated specialty biopharmaceutical company, announced today that the U.S. Food and Drug Administration has approved XIAFLEX (collagenase clostridium histolyticum, or CCH), an in-office, biologic for the treatment of Peyronie's disease. XIAFLEX is the first and only FDA-approved treatment proven effective for PD in men with a palpable plaque and a curvature deformity of 30 degrees or greater at the start of therapy.
The Pennsylvania Department of Public Welfare's stepped-up efforts over the summer to target waste, fraud, and abuse quickly bore fruit in the fall. Adult Medicaid enrollment alone was down 109,000 through November. … Now, DPW has suddenly changed its reporting method. Revised calculations show a decline of just 6,000 participants for the same period. And when December is added in, enrollment is up by 23,000 since August.
As probes of Veterans Affairs hospitals continue, Democratic and Republican candidates are pointing fingers and attempting to find political advantage in the controversy.
› Verified 9 days ago
Charles A Carlton, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1622 8th Avenue, Suite 110, Fort Worth, TX 76104 Phone: 817-926-2561 Fax: 817-921-3708 | |
Paul J Garcia, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5701 Bryant Irvin Rd, Suite 302, Fort Worth, TX 76132 Phone: 817-294-9000 Fax: 817-294-9010 | |
Stevan A Gonzalez, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1250 8th Ave, Suite 515, Fort Worth, TX 76104 Phone: 817-922-4675 Fax: 817-922-4645 | |
Jeremy Aaron Ross, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 800 W Magnolia Ave, Fort Worth, TX 76104 Phone: 817-759-7000 Fax: 817-759-7027 | |
Elie B Choufani, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 601 W Terrell Ave, Fort Worth, TX 76104 Phone: 817-852-8305 | |
Syed Hadi Jafri, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1300 W Terrell Ave Fl 2, Fort Worth, TX 76104 Phone: 817-820-4906 Fax: 817-820-4815 | |
Cheryl K Mcdonald, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1125 College Ave, Fort Worth, TX 76104 Phone: 817-810-9810 Fax: 817-810-9815 |